Corrigendum to "Systemic inflammation alters central 5-HT function as determined by pharmacological MRI" [Neuroimage 75 (2013) 177-186]

Corrigendum to "Systemic inflammation alters central 5-HT function as determined by pharmacological MRI" [Neuroimage 75 (2013) 177-186]

Bibliografske podrobnosti
Main Authors:	Couch, Y, Martin, C, Howarth, C, Raley, J, Khrapitchev, A, Stratford, M, Sharp, T, Sibson, N, Anthony, D
Format:	Journal article
Jezik:	English
Izdano:	Academic Press Inc. 2014

Podobne knjige/članki

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI (vol 75, pg 177, 2013)
od: Couch, Y, et al.
Izdano: (2014)

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.
od: Couch, Y, et al.
Izdano: (2013)

Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.
od: Couch, Y, et al.
Izdano: (2013)

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.
od: Spain, A, et al.
Izdano: (2015)

Pharmacological MRI in animal models: a useful tool for 5-HT research?
od: Martin, C, et al.
Izdano: (2008)

A possible role for 5-HT2C receptors in postsynaptic feedback regulation of 5 HT neurones
od: Raley, J, et al.
Izdano: (2006)

Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain.
od: Preece, M, et al.
Izdano: (2009)

In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism.
od: Boothman, L, et al.
Izdano: (2006)

Important messages in the 'post': recent discoveries in 5-HT neurone feedback control.
od: Sharp, T, et al.
Izdano: (2007)

Mapping of anxiogenic neuronal profiles induced by the GABA inverse agonist FG-7142 and caffeine using pharmacological magnetic resonance imaging
od: Sekar, S, et al.
Izdano: (2010)

Corrigendum: Developments in 177Lu-based radiopharmaceutical therapy and dosimetry
od: Siju C. George, et al.
Izdano: (2024-04-01)

Region-specific effects of a tyrosine-free amino acid mixture on amphetamine-induced changes in BOLD fMRI signal in the rat brain.
od: Preece, M, et al.
Izdano: (2007)

Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.
od: Quérée, P, et al.
Izdano: (2009)

Pruning in poplar plantations by mechanized device Stihl HT-75
od: Danilović Milorad, et al.
Izdano: (2009-01-01)

PHARMACOLOGICAL CHARACTERIZATION OF CENTRAL TACHYKININ-5-HT INTERACTIONS
od: Stoessl, A, et al.
Izdano: (1988)

Pharmacological Approaches to Pain and Consciousness Using Functional Neuroimaging
od: Tracey, I, et al.
Izdano: (2016)

Editorial: In vivo functional neuroimaging for pharmacology
od: Benjamin Vidal, et al.
Izdano: (2023-09-01)

Neuroimaging of animal models of brain disease.
od: Lythgoe, M, et al.
Izdano: (2003)

Combined optogenetic and pharmacological analysis of 5-HT control of cortical microcircuitry
od: So, C
Izdano: (2023)

A Model of Post-Infection Fatigue Is Associated with Increased TNF and 5-HT2A Receptor Expression in Mice.
od: Yvonne Couch, et al.
Izdano: (2015-01-01)

Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels.
od: Licht, C, et al.
Izdano: (2010)

The effect of inflammation on the central 5-HT system in mood disorders
od: Couch, Y
Izdano: (2012)

Evaluation of excitation function for 186W(d,2n)186Re reaction
od: Wang Jimin, et al.
Izdano: (2017-01-01)

186:poster Poverty discrimination
od: Kasper Lippert-Rasmussen, et al.
Izdano: (2022-04-01)

Preclinical study of a new 177Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cells
od: Hossein Behnammanesh, et al.
Izdano: (2020-07-01)

Corrigendum to “Determination of normative reference for the definition of sarcopenia among Filipinos” [Osteoporos. Sarcopenia 2 (2016) 186–190]
od: Michael L. Tee, et al.
Izdano: (2016-12-01)

Evidence that 5-HT2 receptor agonist induced inhibtion of 5-HT cell firing is mediated by central and not peripheral 5-HT2 receptors
od: Boothman, L, et al.
Izdano: (2003)

Comparison of MRI signatures in pattern I and II multiple sclerosis models.
od: Serres, S, et al.
Izdano: (2009)

Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock.
od: Burnet, P, et al.
Izdano: (1999)

CORRELATIONS AT LARGE SCALES AND THE ONSET OF TURBULENCE IN THE FAST SOLAR WIND (vol 778, pg 177, 2013)
od: Wicks, RT, et al.
Izdano: (2014)

THE NUCLEAR MAGNETIC-MOMENT OF IR-186
od: Allsop, A, et al.
Izdano: (1982)

5-HT and depression: is the glass half-full?
od: Sharp, T, et al.
Izdano: (2011)

Fast scan cyclic voltammetry evidence that 5-HT transporter overexpression impairs the function of 5-HT nerve terminals
od: Jennings, K, et al.
Izdano: (2008)

Improved Detection of Molecularly Targeted Iron Oxide Particles in Small Animals with High Resolution MRI
od: Kinchesh, P, et al.
Izdano: (2019)

Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
od: Hughes, Z, et al.
Izdano: (2007)

Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate co-transmission
od: Sengupta, A, et al.
Izdano: (2017)

Non-linear relationship between 5-HT transporter gene expression and frequency sensitivity of 5-HT signals.
od: Jennings, K, et al.
Izdano: (2010)

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry
od: Siju C. George, et al.
Izdano: (2024-04-01)

Quantitative Bayesian model-based analysis of amide proton transfer MRI
od: Chappell, M, et al.
Izdano: (2013)

Quantitative Bayesian model-based analysis of amide proton transfer MRI.
od: Chappell, M, et al.
Izdano: (2013)